Spectral Medical Inc. (EDTXF)
USD 0.58
(-0.12%)
USD 0.58
(-0.12%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 662 Thousand CAD | -20.71% |
| 2022 | 8.23 Million CAD | -15.37% |
| 2021 | 9.72 Million CAD | -6.59% |
| 2020 | 10.41 Million CAD | 49.18% |
| 2019 | 6.98 Million CAD | 33.66% |
| 2018 | 5.22 Million CAD | -20.65% |
| 2017 | 6.58 Million CAD | -46.47% |
| 2016 | 12.29 Million CAD | 6.91% |
| 2015 | 11.5 Million CAD | -2.63% |
| 2014 | 11.81 Million CAD | -6.89% |
| 2013 | 12.68 Million CAD | 26.02% |
| 2012 | 10.06 Million CAD | 14.84% |
| 2011 | 8.76 Million CAD | 1.48% |
| 2010 | 8.63 Million CAD | 72.09% |
| 2009 | 5.01 Million CAD | 29.32% |
| 2008 | 3.88 Million CAD | -0.87% |
| 2007 | 3.91 Million CAD | 24.64% |
| 2006 | 3.14 Million CAD | -72.06% |
| 2005 | 11.24 Million CAD | -8.98% |
| 2004 | 12.35 Million CAD | -9.46% |
| 2003 | 13.64 Million CAD | -0.75% |
| 2002 | 13.74 Million CAD | -0.25% |
| 2001 | 13.77 Million CAD | -9.94% |
| 2000 | 15.3 Million CAD | -26.44% |
| 1999 | 20.8 Million CAD | 14.29% |
| 1998 | 18.2 Million CAD | 18.95% |
| 1997 | 15.3 Million CAD | -3.16% |
| 1996 | 15.8 Million CAD | 31.67% |
| 1995 | 12 Million CAD | 126.42% |
| 1994 | 5.3 Million CAD | 70.97% |
| 1993 | 3.1 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.4 Million CAD | -31.09% |
| 2024 Q2 | 2.01 Million CAD | -94.08% |
| 2023 Q3 | 2.59 Million CAD | -12.88% |
| 2023 FY | 6.52 Million CAD | -20.71% |
| 2023 Q4 | 2.03 Million CAD | -21.72% |
| 2023 Q1 | 2 Million CAD | 307.45% |
| 2023 Q2 | 2.98 Million CAD | 48.6% |
| 2022 Q1 | 3.01 Million CAD | 10.87% |
| 2022 Q2 | 2.92 Million CAD | -3.11% |
| 2022 Q3 | 3.25 Million CAD | 11.42% |
| 2022 FY | 8.23 Million CAD | -15.37% |
| 2022 Q4 | -967 Thousand CAD | -129.68% |
| 2021 Q2 | 2.58 Million CAD | 16.99% |
| 2021 FY | 9.72 Million CAD | -6.59% |
| 2021 Q4 | 2.72 Million CAD | 23.5% |
| 2021 Q3 | 2.2 Million CAD | -14.87% |
| 2021 Q1 | 2.21 Million CAD | 0.64% |
| 2020 Q2 | 2.06 Million CAD | -53.12% |
| 2020 FY | 10.41 Million CAD | 49.18% |
| 2020 Q4 | 2.19 Million CAD | 24.87% |
| 2020 Q1 | 4.39 Million CAD | 83.93% |
| 2020 Q3 | 1.76 Million CAD | -14.51% |
| 2019 Q2 | 1.66 Million CAD | 37.23% |
| 2019 Q1 | 1.21 Million CAD | 14.74% |
| 2019 Q4 | 2.38 Million CAD | 39.54% |
| 2019 FY | 6.98 Million CAD | 33.66% |
| 2019 Q3 | 1.71 Million CAD | 2.76% |
| 2018 Q1 | 1.66 Million CAD | -0.78% |
| 2018 FY | 5.22 Million CAD | -20.65% |
| 2018 Q4 | 1.05 Million CAD | 1.93% |
| 2018 Q3 | 1.03 Million CAD | -29.1% |
| 2018 Q2 | 1.46 Million CAD | -11.97% |
| 2017 Q4 | 1.67 Million CAD | 24.15% |
| 2017 Q1 | 1.68 Million CAD | 17.0% |
| 2017 Q2 | 1.87 Million CAD | 10.91% |
| 2017 Q3 | 1.35 Million CAD | -27.81% |
| 2017 FY | 6.58 Million CAD | -46.47% |
| 2016 Q1 | 3.68 Million CAD | 32.92% |
| 2016 Q2 | 4.09 Million CAD | 11.14% |
| 2016 Q4 | 1.44 Million CAD | -53.21% |
| 2016 Q3 | 3.08 Million CAD | -24.73% |
| 2016 FY | 12.29 Million CAD | 6.91% |
| 2015 Q2 | 2.91 Million CAD | -0.75% |
| 2015 Q1 | 2.93 Million CAD | 4.11% |
| 2015 FY | 11.5 Million CAD | -2.63% |
| 2015 Q4 | 2.77 Million CAD | -3.89% |
| 2015 Q3 | 2.88 Million CAD | -1.06% |
| 2014 Q4 | 2.81 Million CAD | 16.87% |
| 2014 Q1 | 3.64 Million CAD | -9.86% |
| 2014 Q2 | 2.94 Million CAD | -19.23% |
| 2014 Q3 | 2.41 Million CAD | -17.96% |
| 2014 FY | 11.81 Million CAD | -6.89% |
| 2013 Q1 | 2.46 Million CAD | 1.4% |
| 2013 Q4 | 4.03 Million CAD | 41.68% |
| 2013 Q3 | 2.85 Million CAD | -14.44% |
| 2013 Q2 | 3.33 Million CAD | 35.08% |
| 2013 FY | 12.68 Million CAD | 26.02% |
| 2012 Q4 | 2.43 Million CAD | -0.53% |
| 2012 FY | 10.06 Million CAD | 14.84% |
| 2012 Q3 | 2.44 Million CAD | -3.7% |
| 2012 Q2 | 2.53 Million CAD | -4.19% |
| 2012 Q1 | 2.65 Million CAD | 8.25% |
| 2011 Q4 | 2.44 Million CAD | 20.24% |
| 2011 Q2 | 2.27 Million CAD | 6.92% |
| 2011 FY | 8.76 Million CAD | 1.48% |
| 2011 Q1 | 2.12 Million CAD | -14.5% |
| 2011 Q3 | 2.03 Million CAD | -10.31% |
| 2010 Q4 | 2.48 Million CAD | 31.72% |
| 2010 Q2 | 1.77 Million CAD | -28.83% |
| 2010 FY | 8.63 Million CAD | 72.09% |
| 2010 Q1 | 2.49 Million CAD | 39.25% |
| 2010 Q3 | 1.88 Million CAD | 6.2% |
| 2009 Q3 | 999 Thousand CAD | -15.77% |
| 2009 Q1 | 1.04 Million CAD | 2.86% |
| 2009 Q2 | 1.18 Million CAD | 13.71% |
| 2009 FY | 5.01 Million CAD | 29.32% |
| 2009 Q4 | 1.79 Million CAD | 79.28% |
| 2008 Q1 | 976 Thousand CAD | -19.21% |
| 2008 Q4 | 1.01 Million CAD | 10.82% |
| 2008 Q3 | 915 Thousand CAD | -6.44% |
| 2008 Q2 | 978 Thousand CAD | 0.2% |
| 2008 FY | 3.88 Million CAD | -0.87% |
| 2007 FY | 3.91 Million CAD | 24.64% |
| 2007 Q2 | 965 Thousand CAD | 14.34% |
| 2007 Q4 | 1.2 Million CAD | 29.47% |
| 2007 Q3 | 933 Thousand CAD | -3.32% |
| 2007 Q1 | 844 Thousand CAD | 0.0% |
| 2006 FY | 3.14 Million CAD | -72.06% |
| 2006 Q2 | 1.03 Million CAD | -54.49% |
| 2006 Q1 | 2.27 Million CAD | 9.77% |
| 2006 Q3 | 902 Thousand CAD | -12.68% |
| 2005 Q3 | 2.16 Million CAD | -8.74% |
| 2005 Q4 | 2.06 Million CAD | -4.3% |
| 2005 FY | 11.24 Million CAD | -8.98% |
| 2005 Q1 | 2.3 Million CAD | -26.28% |
| 2005 Q2 | 2.36 Million CAD | 2.82% |
| 2004 Q1 | 3.31 Million CAD | 4.74% |
| 2004 FY | 12.35 Million CAD | -9.46% |
| 2004 Q4 | 3.12 Million CAD | 1.92% |
| 2004 Q3 | 3.06 Million CAD | 11.5% |
| 2004 Q2 | 2.74 Million CAD | -17.02% |
| 2003 FY | 13.64 Million CAD | -0.75% |
| 2003 Q2 | 2.47 Million CAD | -32.65% |
| 2003 Q3 | 2.84 Million CAD | 14.99% |
| 2003 Q4 | 3.16 Million CAD | 11.14% |
| 2003 Q1 | 3.67 Million CAD | 19.24% |
| 2002 FY | 13.74 Million CAD | -0.25% |
| 2002 Q4 | 3.08 Million CAD | -12.27% |
| 2002 Q3 | 3.51 Million CAD | 14.84% |
| 2002 Q2 | 3.05 Million CAD | -4.59% |
| 2002 Q1 | 3.2 Million CAD | -17.33% |
| 2001 FY | 13.77 Million CAD | -9.94% |
| 2001 Q1 | 3.32 Million CAD | 7.62% |
| 2001 Q2 | 3.08 Million CAD | -7.26% |
| 2001 Q3 | 3.38 Million CAD | 10.0% |
| 2001 Q4 | 3.87 Million CAD | 14.46% |
| 2000 FY | 15.3 Million CAD | -26.44% |
| 2000 Q3 | 3.83 Million CAD | 6.42% |
| 2000 Q4 | 3.08 Million CAD | -19.45% |
| 2000 Q1 | 3.3 Million CAD | -13.16% |
| 2000 Q2 | 3.6 Million CAD | 9.09% |
| 1999 Q2 | 3.7 Million CAD | -21.28% |
| 1999 Q4 | 3.8 Million CAD | -7.32% |
| 1999 FY | 20.8 Million CAD | 14.29% |
| 1999 Q1 | 4.7 Million CAD | -11.32% |
| 1999 Q3 | 4.1 Million CAD | 10.81% |
| 1998 Q3 | 6 Million CAD | 15.38% |
| 1998 Q4 | 5.3 Million CAD | -11.67% |
| 1998 Q2 | 5.2 Million CAD | 18.18% |
| 1998 Q1 | 4.4 Million CAD | -16.98% |
| 1998 FY | 18.2 Million CAD | 18.95% |
| 1997 FY | 15.3 Million CAD | -3.16% |
| 1997 Q4 | 5.3 Million CAD | 17.78% |
| 1997 Q3 | 4.5 Million CAD | 9.76% |
| 1997 Q1 | 4.8 Million CAD | 23.08% |
| 1997 Q2 | 4.1 Million CAD | -14.58% |
| 1996 Q1 | 3.4 Million CAD | -20.93% |
| 1996 Q4 | 3.9 Million CAD | 11.43% |
| 1996 FY | 15.8 Million CAD | 31.67% |
| 1996 Q3 | 3.5 Million CAD | 9.38% |
| 1996 Q2 | 3.2 Million CAD | -5.88% |
| 1995 FY | 12 Million CAD | 126.42% |
| 1995 Q4 | 4.3 Million CAD | -8.51% |
| 1995 Q1 | 4.1 Million CAD | 64.0% |
| 1995 Q3 | 4.7 Million CAD | 17.5% |
| 1995 Q2 | 4 Million CAD | -2.44% |
| 1994 Q1 | 1.8 Million CAD | 20.0% |
| 1994 Q3 | 3.3 Million CAD | 65.0% |
| 1994 Q4 | 2.5 Million CAD | -24.24% |
| 1994 FY | 5.3 Million CAD | 70.97% |
| 1994 Q2 | 2 Million CAD | 11.11% |
| 1993 Q4 | 1.5 Million CAD | 15.38% |
| 1993 FY | 3.1 Million CAD | 0.0% |
| 1993 Q1 | 801.25 Thousand CAD | 4.57% |
| 1993 Q3 | 1.3 Million CAD | 62.5% |
| 1993 Q2 | 800 Thousand CAD | -0.16% |
| 1992 Q3 | 1.12 Million CAD | 134.72% |
| 1992 Q2 | 478.46 Thousand CAD | 0.0% |
| 1992 Q4 | 766.24 Thousand CAD | -31.77% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | 36.892% |
| Arrayit Corporation | 6.19 Million USD | 89.318% |
| Atlantic International Corp. | 5.57 Million USD | 88.133% |
| Biocept, Inc. | 29.4 Million USD | 97.748% |
| Bioqual, Inc. | 7.44 Million USD | 91.113% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | 14.264% |
| DermTech, Inc. | 104.01 Million USD | 99.364% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 99.602% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 97.074% |
| iMD Companies, Inc. | 151.8 Thousand USD | -336.074% |
| IDenta Corp. | 662.97 Thousand USD | 0.147% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 96.728% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -1602.631% |
| InVitro International | 661.32 Thousand USD | -0.102% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | 90.673% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -1039.18% |
| Medical Imaging Corp. | 1.91 Million USD | 65.38% |
| NovelStem International Corp. | 3.53 Million USD | 81.288% |
| Optigenex Inc. | 1.28 Million USD | 48.597% |
| PharmChem, Inc. | 2.93 Million USD | 77.416% |
| Proteome Sciences plc | 3.26 Million USD | 79.743% |
| Response Genetics, Inc | 25.31 Million USD | 97.385% |
| Rennova Health, Inc. | 7.67 Million USD | 91.378% |
| RushNet, Inc. | 1.78 Million USD | 63.003% |
| ScreenPro Security Inc. | 3.23 Million USD | 79.561% |
| Stella Diagnostics Inc. | 11.42 Million USD | 94.207% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | 90.985% |
| Todos Medical Ltd. | 14.05 Million USD | 95.291% |